Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q4 2025
Institutional positions in Calidi Biotherapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +5 vs. Q3 2025
- Shares held
- 448.3K
- +215.8K (+92.8%) vs. Q3 2025
- Total value
- $524.7K
- +$171.1K (+48.4%) vs. Q3 2025
- New holders
- 8
- 7 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $655.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.53M |
| Q4 2023 | 25 | $2.83M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $39.0M |
| Q1 2023 | 27 | $40.6M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $205.5M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $164.7M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $1 | 0.00% | +1 | New |
| Evermay Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 28 | $33 | 0.00% | +28 | New |
| CVA Family Office, LLC | 42 | $49 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $53 | 0.00% | +16+53.3% | Added |
| SBI Securities Co., Ltd. | 46 | $54 | 0.00% | 00.0% | Unchanged |
| Reyes Financial Architecture, Inc. | 100 | $117 | 0.00% | 00.0% | Unchanged |
| Tradewinds Capital Management, LLC | 101 | $119 | 0.00% | 00.0% | Unchanged |
| Barrett & Company, Inc. | 292 | $342 | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 1,042 | $1.22K | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 1,042 | $1.22K | 0.00% | 00.0% | Unchanged |
| Apollo Management Holdings, L.P. | 1,042 | $1.22K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,467 | $1.72K | 0.00% | +1,080+279.1% | Added |
| Advisor Group Holdings, Inc. | 2,106 | $2.46K | 0.00% | +1,706+426.5% | Added |
| Tower Research Capital LLC (TRC) | 2,774 | $3.25K | 0.00% | +2,774 | New |
| UBS Group AG | 7,514 | $8.79K | 0.00% | +4,950+193.1% | Added |
| Farther Finance Advisors, LLC | 10,000 | $11.7K | 0.00% | +10,000 | New |
| Jane Street Group, LLC | 11,491 | $13.4K | 0.00% | +11,491 | New |
| Northern Trust Corp | 17,758 | $20.8K | 0.00% | +17,758 | New |
| Belpointe Asset Management LLC | 19,971 | $23.4K | 0.00% | −21,671−52.0% | Reduced |
| RS Crum Inc. | 20,256 | $23.7K | 0.00% | +5,000+32.8% | Added |
| Virtu Financial LLC | 21,243 | $25.0K | 0.00% | +21,243 | New |
| FMR LLC | 22,013 | $25.8K | 0.00% | +21,888+17,510.4% | Added |
| Vanguard Group Inc | 34,728 | $40.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 41,929 | $49.1K | 0.00% | +12,334+41.7% | Added |
| HighTower Advisors, LLC | 83,523 | $97.7K | 0.00% | −1,433−1.7% | Reduced |
| DRW Securities, LLC | 147,767 | $172.9K | 0.01% | +147,767 | New |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |